[47C1-47C1];[47F1-47F1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
47C1;47F1
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Lethal in combination with Df(2R)BSC314.
The presence of P+PBac{XP5.WH5}BSC327 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d01591 to be at Release 3 genomic coordinate 6353307 on chromosome arm 2R. This corresponds to 47F1 on the Release 5 genome map. The predicted position of PBac{WH}CG12938f06616 on the Release 5 map is 47C1. Consequently, the cytological breakpoints of Df(2R)BSC327 are predicted to be 47C1;47F1.